Mumbai, India, April 27, 2026 and Jersey City, New Jersey, April 26, 2026 – Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) …

1 day ago · Organon stockholders to receive US$ 14.00 per share in cash The deal values Organon at EV of US$ 11.75 billion Combined Business leverages complementary portfolios and global scale for …

1 day ago · Sun Pharmaceutical Industries will buy U.S. drugmaker Organon & Co in an all-cash deal valued at about $11.75 billion including debt, for ‌the largest overseas acquisition by an Indian ...

1 day ago · Sun Pharma's historic acquisition of Organon marks a new chapter in the global pharmaceutical industry. With a vision of 'reaching people and touching lives,' Sun Pharma is set to …

23 hours ago · Already the largest biopharma company in India, generics powerhouse Sun Pharma has doubled in size with its acquisition (PDF) of women’s health leader Organon. With its $11.75 billion …

23 hours ago · Sun Pharma has offered to pay $14 a share in an all-cash deal, putting the Indian drugmaker on track to become one of the top three global players in women’s health.

1 day ago · Sun Pharma has signed a definitive agreement to acquire Organon in a transaction with an enterprise valuation of $11.75bn in cash.

1 day ago · Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for …

1 day ago · India's Sun Pharmaceutical Industries has agreed to acquire U.S.-listed healthcare company Organon in a deal valuing the company at $11.75 billion, putting the Indian drugmaker on track to …

1 day ago · Organon's shares had already surged roughly 31% the previous Friday, a move that followed an Economic Times report that Sun Pharma was pursuing a deal to buy the company, …